Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 3,266 | 2,238 | 2,220 | 833 | 1,071 |
| Cost of Goods | 755 | 1,359 | 701 | 759 | 354 |
| Gross Profit | 2,511 | 879 | 1,519 | 74 | 717 |
| Operating Expenses | 31,580 | 30,222 | 28,062 | 22,113 | 21,196 |
| Operating Income | -28,314 | -28,984 | -25,842 | -21,280 | -20,125 |
| Interest Expense | 2,141 | 2,170 | 2,157 | 2,134 | 2,128 |
| Other Income | 43 | 42 | 51 | 102 | 298 |
| Pre-tax Income | -30,412 | -31,112 | -27,948 | -23,312 | -21,955 |
| Net Income Continuous | -30,412 | -31,112 | -27,948 | -23,312 | -21,955 |
| Net Income | $-30,412 | $-31,112 | $-27,948 | $-23,312 | $-21,955 |
| EPS Basic Total Ops | -1,225.00 | -1,325.00 | -1,250.00 | -1,050.00 | -1,350.00 |
| EPS Basic Continuous Ops | -1,233.13 | -1,339.76 | -1,246.99 | -1,046.25 | -1,346.54 |
| EPS Diluted Total Ops | -1,225.00 | -1,325.00 | -1,250.00 | -1,050.00 | -1,350.00 |
| EPS Diluted Continuous Ops | -1,233.13 | -1,339.76 | -1,246.99 | -1,046.25 | -1,346.54 |
| EBITDA(a) | $-27,788 | $-28,474 | $-25,353 | $-20,796 | $-19,642 |